VEGF and Intraocular Neovascularization: From Discovery to Therapy

被引：77
|
作者：
Ferrara, Napoleone [1 ]
机构：
[1] Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA
来源：
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY | 2016年 / 5卷 / 02期
关键词：
VEGF; angiogenesis; tyrosine kinase; age-related macular degeneration; antibody; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; TYROSINE KINASE; CHOROIDAL NEOVASCULARIZATION; RANIBIZUMAB TREATMENT; EXTRACELLULAR-MATRIX; CELLS SECRETE; BASIC SCIENCE;
D O I：
10.1167/tvst.5.2.10
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
I am honored and humbled to be one of the awardees of the 2014 A. Champalimaud Vision Award. I offer my heartfelt thanks to the Champalimaud Foundation President, Leonor Beleza, and to the Award Committee Members for this wonderful recognition. I feel especially fortunate to have had the opportunity to witness my scientific discoveries move from the bench to the clinic. Scientific discovery is hugely exciting, but the ability to translate that work into potentially helping someone lead a better life is even more fulfilling. This Award is dedicated to the patients.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Inhibition of retinal neovascularization by intraocular gene delivery of soluble VEGF receptors
    Scaria, A
    Pechan, P
    Lukason, M
    Rubin, H
    Wadsworth, S
    [J]. MOLECULAR THERAPY, 2004, 9 : S198 - S198
  • [2] VEGF: From Discovery to Therapy: The Champalimaud Award Lecture
    Miller, Joan W.
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2016, 5 (02):
  • [3] Intraocular neovascularization
    Yoshida, A
    Yoshida, S
    Ishibashi, T
    Inomata, H
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 1999, 14 (04) : 1287 - 1294
  • [4] Corneal Neovascularization: An Anti-VEGF Therapy Review
    Chang, Jin-Hong
    Garg, Nitin K.
    Lunde, Elisa
    Han, Kyu-Yeon
    Jain, Sandeep
    Azar, Dimitri T.
    [J]. SURVEY OF OPHTHALMOLOGY, 2012, 57 (05) : 415 - 429
  • [5] Intraocular gutless adenoviral-vectored VEGF; A model of anterior segment neovascularization (NV)
    Oshima, S
    Oshima, Y
    Takahashi, K
    Reddy, P
    Ganesh, S
    Brann, T
    Liau, G
    Kaleko, M
    Connolly, S
    Campochiaro, PA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U542 - U542
  • [6] Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization
    Oshima, Y
    Takahashi, K
    Oshima, S
    Saishin, Y
    Saishin, Y
    Silva, RL
    Liang, XL
    Reddy, PS
    Ganesh, S
    Brann, T
    Liau, G
    Kaleko, M
    Connelly, S
    Campochiaro, PA
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 199 (03) : 399 - 411
  • [7] Systemic or intraocular administration of VEGF receptor kinase inhibitors causes regression of choroidal neovascularization
    Takahashi, K
    Saishin, Y
    Silva, RL
    Saishin, Y
    Bingaman, DP
    Campochiaro, PA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [8] Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization
    Xiaojuan Fan
    Ning Gao
    Jingming Li
    Jianqin Lei
    Qianyan Kang
    [J]. Molecular and Cellular Biochemistry, 2018, 441 : 173 - 179
  • [9] Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization
    Fan, Xiaojuan
    Gao, Ning
    Li, Jingming
    Lei, Jianqin
    Kang, Qianyan
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 441 (1-2) : 173 - 179
  • [10] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Teo, Kelvin Yi Chong
    Ng, Wei Yan
    Lee, Shu Yen
    Cheung, Chui Ming Gemmy
    [J]. DRUGS, 2016, 76 (11) : 1119 - 1133
12345